Btk-deficiency protects against several spontaneous autoimmune diseases in mouse models (12, 13) and clinical trials investigating the efficacy of BTK inhibitors in human autoimmune disease are ongoing (reviewed in (29)). This evidence concerns the gene BTK and autoimmune disease.